Company: AEMD
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001683168-25-002685
Chunk: 34

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 34
---
 and in two subsequent Annual Meetings of Stockholders. In the event stockholder
approval for Proposal No. 2 is not obtained at the Special Meeting, we will be required to call seek approval of such provision in the
two subsequent Annual Meetings.

<div align='center'>OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE INDUCEMENT WARRANTS AND THE RESET OF EXERCISE PRICE AS SET FORTH IN PROPOSAL 2.</div>

| 18 |

<div align='center'>PROPOSAL NO. 3 – ADJOURNMENT OF THE SPECIAL MEETING.</div>

Our stockholders may be asked to consider and act
upon one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of any of the
proposals set forth in this Proxy Statement.

If a quorum is not present at the Special Meeting,
our stockholders may be asked to vote on the proposal to adjourn the Special Meeting to solicit additional proxies. If a quorum is present
at the Special Meeting, but there are not sufficient votes at the time of the Special Meeting to approve any of the foregoing proposals,
our stockholders may also be asked to vote on the proposal to approve the adjournment of the Special Meeting to permit further solicitation
of proxies in favor of any of the proposals.

If the adjournment proposal is submitted for a vote
at the Special Meeting, and if our stockholders vote to approve the adjournment proposal, the Special Meeting may be adjourned to another
place, or a later date or dates, to enable us to solicit additional proxies in favor of any of the proposals. If the adjournment proposal
is approved, and the Special Meeting is adjourned, we will use the additional time to solicit additional proxies in favor of the relevant
proposals to be presented at the Special Meeting, including the solicitation of proxies from stockholders that have previously voted against
any of the proposals.

Our Board of Directors believes that, if the number
of shares of our common stock voting in favor of any of the proposals at the Special Meeting is insufficient to approve such proposals,
it is in the best interests of our stockholders to enable us, if we so choose and for a limited period of time, to continue to seek to
obtain a sufficient number of additional votes in favor of such proposals. Any signed proxies received by us in which